Hydroxyprogesterone Caproate (Mylan Institutional LLC)


Welcome to the PulseAid listing for the Hydroxyprogesterone Caproate drug offered from Mylan Institutional LLC. This Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Institutional LLC
NON-PROPRIETARY NAME: Hydroxyprogesterone Caproate
SUBSTANCE NAME: HYDROXYPROGESTERONE CAPROATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Progesterone Congeners [Chemical/Ingredient],Progestin [EPC]
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-09-22
END MARKETING DATE: 0000-00-00


Hydroxyprogesterone Caproate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionHydroxyprogesterone Caproate from Mylan Institutional LLC
LABELER NAME: Mylan Institutional LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/mL)
START MARKETING DATE: 2017-09-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67457-886_1663b15d-8298-4d47-82d9-51515b16eaa0
PRODUCT NDC: 67457-886
APPLICATION NUMBER: ANDA200271

Other HYDROXYPROGESTERONE CAPROATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AMAG Pharmaceuticals, Inc.Makena
ANI Pharmaceuticals, Inc.Hydroxyprogesterone Caproate
Mylan Institutional LLCHydroxyprogesterone Caproate